Rms Pharma India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 11 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 110.95%
(FY 2016)
- Profit -310.72%
(FY 2016)
- Ebitda -238.94%
(FY 2016)
- Net Worth -123.05%
(FY 2016)
- Total Assets 10.90%
(FY 2016)
About Rms Pharma India
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M, as per Ministry of Corporate Affairs (MCA) records.
Mammootty Surumy and Mohammed Sayeed serve as directors at the Company.
- CIN/LLPIN
U24232KA2013PTC067833
- Company No.
067833
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Feb 2013
- Date of AGM
27 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Rms Pharma India?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mohammed Sayeed  | Director | 13-Feb-2013 | Current |
| Mammootty Surumy | Director | 13-Feb-2013 | Current |
Financial Performance of Rms Pharma India.
Rms Pharma India Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 110.95% increase. The company also saw a substantial fall in profitability, with a 310.72% decrease in profit. The company's net worth observed a substantial decline by a decrease of 123.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Rms Pharma India?
In 2017, Rms Pharma India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Thameen Healthcare Private LimitedActive 7 years 2 months
Mammootty Surumy and Mohammed Sayeed are mutual person
- New Hope Surgical Centers Private LimitedActive 5 years 2 months
Mammootty Surumy and Mohammed Sayeed are mutual person
- Thc Healthcare Private LimitedActive 6 years 7 months
Mammootty Surumy and Mohammed Sayeed are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Rms Pharma India?
Unlock and access historical data on people associated with Rms Pharma India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Rms Pharma India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Rms Pharma India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
